結果 : checkmate 227 regimen
5:13

CheckMate-227 Regimen Safety Profile

OncLive
87 回視聴 - 3 年前
2:33

CheckMate 227: chemo-free NSCLC treatment

VJOncology
285 回視聴 - 4 年前
4:10

When to Use the CheckMate-227 Regimen

OncLive
585 回視聴 - 4 年前
6:51

Researcher comment: Three-year data from CheckMate 227 | Suresh Ramalingam

Medicine Matters oncology
182 回視聴 - 4 年前
2:44

Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227

ASCOcancer
7,887 回視聴 - 1 年前
6:13

CheckMate-227: Testing Ipilimumab/Nivolumab in NSCLC

OncLive
411 回視聴 - 5 年前
6:07

Interpreting the Results of CheckMate-227 in NSCLC

OncLive
369 回視聴 - 5 年前
5:51

CheckMate-227 and the Role of TMB in NSCLC

OncLive
142 回視聴 - 5 年前
3:45

ASCO 2020 Data Update: CheckMate 227

OncLive
233 回視聴 - 3 年前
13:07

Nivo/Ipi vs. Chemo: Key Results from CheckMate 227 (BMIC-034)

BeaconMedIC
386 回視聴 - 6 年前
2:26

CheckMate 227 update

VJOncology
98 回視聴 - 4 年前
2:21

Expert comment: The CheckMate 227 study | Sanjay Popat

Medicine Matters oncology
369 回視聴 - 4 年前
1:42

Dr. Patel on CheckMate-227 Results in Advanced NSCLC

OncLive
229 回視聴 - 4 年前
3:04

Checkmate 227: Final analysis for the non small cell lung cancer trial

ecancer
269 回視聴 - 4 年前
0:50

CheckMate 227 Induced Manageable Toxicities With Immunotherapy Combination in NSCLC

Targeted Oncology
86 回視聴 - 4 年前
5:31

CheckMate-227: Nivolumab + Ipilimumab in mNSCLC

OncLive
233 回視聴 - 5 年前
9:04

Case Based Panel Discussion - Stage3 NSCLC - Checkmate 227 Immuno Combo, Another Treatment Option?

GRACE - Global Resource for Advancing Cancer Education
139 回視聴 - 4 年前
2:17

Dr. Borghaei on the CheckMate-227 Trial in NSCLC

OncLive
412 回視聴 - 4 年前
5:51

NSCLC: Use of TMB in CheckMate-227

OncLive
69 回視聴 - 5 年前
17:08

Three-Year Update From the CheckMate 227 Clinical Trial for Advanced NSCLC

OncLive
818 回視聴 - 4 年前